GENEVA: The World Health Organization (WHO) inspections scheduled for March of Russian production of the Sputnik V coronavirus vaccine will depend on the UN security assessment and the development of the situation in the region.
A representative of the WHO headquarters in Geneva said that, commenting on possible changes in the organization’s plans in connection with the start of Russia’s special military operation in Ukraine. Consideration of the application of the Russian Direct Investment Fund (RDIF) to assess the safety, effectiveness and quality of the production of the Sputnik V coronavirus vaccine developed by the Center. Gamaleya continues, he assured.
The European Medicines Agency (EMA) also continues to test Sputnik V, an EMA representative said.
- In total, 144 countries received vaccines under the COVAX program. There are no Russian drugs among them yet.
The evaluation of the quality, safety and effectiveness of vaccine production is carried out by WHO to include drugs in the list of products recommended by the organization for procurement in an Emergency Use Listing (EUL). This is a prerequisite for the supply of vaccines through the COVAX program launched in April 2020. The goal of the initiative is to provide vaccines for COVID-19 to low and middle-income countries.
Send your News, Article, Pictorial
WhatsApp: +923132434567 / +923332100737 / +923002601786
Send your comments on enewspaper Social Media
Facebook: shujaullahk – https://www.facebook.com/Enewspapercompk-182394028490643
Twitter: KhanShujaullah – https://www.twitter.com/home
LinkedIn: shuja-ullah-khan – https://www.linkedin.com/feed/